Spondyloarthritis & psoriatic arthritis
Diverse Treatment Goals in Psoriatic Arthritis: Insights From Participants in the PARC Cohort
Authors' conclusion
The heterogeneity of treatment goals underscores the importance of eliciting patient treatment goals to guide personalized management.
Study context
- Population
- Participants with PsA in the Psoriatic Arthritis Research Consortium (PARC), 2017–2020
- Participants
- 193 participants
- Outcome
- Patient-reported treatment goals: top improvement priority and treatment impact goals
- Follow-up
- Enrollment or therapy initiation
Methodological detailsopen-ended questions, themes matched to PRO items
- Open-ended questions
- Themes matched to PRO items
Main finding
As reported in the abstract
Patient-reported treatment goals
- Improvement priority: decreasing pain
- 56%
- Improvement priority: improving skin
- 12%
- Impact goal: decreasing pain
- 24%
- Impact goal: general improvement in life
- 18%
- Impact goal: ability to be more active
- 15%
- Impact goal: participate in recreational activities
- 9%
- Impact goal: function at work
- 11%
- Impact goal: exercise
- 5%
Observational data: associations, not effects.
Further findings
Scores of PRO items matched to improvement priority or impact goal
- Scores for PRO items matching the patient's priority or impact goal were higher than for the remainder of the population (eg, fatigue item scores higher among those identifying fatigue as priority)
Original publication
Diverse Treatment Goals in Psoriatic Arthritis: Insights From Participants in the PARC Cohort. Arthritis Care Res (Hoboken). Published 23 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →